Limone, Francesco http://orcid.org/0000-0002-2482-8801
Mordes, Daniel A. http://orcid.org/0000-0002-8344-2140
Couto, Alexander
Joseph, Brian J. http://orcid.org/0000-0001-9876-0021
Mitchell, Jana M.
Therrien, Martine http://orcid.org/0000-0003-3150-4052
Ghosh, Sulagna Dia http://orcid.org/0000-0003-1833-7296
Meyer, Daniel http://orcid.org/0000-0003-4720-9891
Zhang, Yingying
Goldman, Melissa
Bortolin, Laura
Cobos, Inma http://orcid.org/0000-0002-2043-1890
Stevens, Beth
McCarroll, Steven A. http://orcid.org/0000-0002-6954-8184
Kadiu, Irena
Burberry, Aaron
Pietiläinen, Olli
Eggan, Kevin
Article History
Received: 13 October 2022
Accepted: 1 May 2024
First Online: 21 June 2024
Competing interests
: I.K. is an employee at UCB Pharma and holds stock options. K.E. is a cofounder of Q-State Biosciences, Quralis, Enclear Therapies and is group vice-president at BioMarin Pharmaceutical. The remaining authors declare no competing interests.